Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses

(2012) Mario Poljak et al.   VACCINE

Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting

(2011) F. M. Carozzi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening

(2011) M. Poljak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

(2011) D. A. M. Heideman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Principles and analytical performance of Abbott RealTime High Risk HPV test

(2009) Shihai Huang et al.   JOURNAL OF CLINICAL VIROLOGY

Validation of high-risk HPV tests for primary cervical screening

(2009) C.J.L.M. Meijer et al.   JOURNAL OF CLINICAL VIROLOGY

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER